FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2976456009> ?p ?o ?g. }

• W2976456009 endingPage "172680" @default.
• W2976456009 startingPage "172680" @default.
• W2976456009 abstract "Psoriasis is a common dermatosis causing considerable inconvenience to 4% of the general population. Traditional psoriasis treatments often cause side effects, drug resistance and complications, necessitating development of safer and more effective treatments. In this study, we screened over 600 natural compounds to identify viability inhibitors of human HaCaT keratinocytes cultured in vitro. The results showed that nitidine chloride was a highly effective inhibitor. Further studies revealed that nitidine chloride inhibited HaCaT proliferation and induced S phase cell cycle arrest; these effects were associated with reduced DNA synthesis, decreased Ki67, cyclin A, and cyclin D1 levels, and increased p53 protein expression. Nitidine chloride also significantly downregulated bcl-2 and upregulated bax, cleaved caspase-9 and cleaved caspase-3. Mechanistic studies revealed that nitidine chloride-induced apoptosis involved the c-Jun N-terminal kinase (JNK) pathway. More importantly, in 12-O-tetradecanoyl-phorbol-13-acetate (TPA)- and imiquimod (IMQ)-induced epidermal hyperplasia and inflammation models, nitidine chloride inhibited topical edema in mouse ear and back skin, substantially reducing tissue thickness and weight. In some cases, nitidine chloride also ameliorated conditions caused by TPA and IMQ, such as angiogenesis and infiltration of large numbers of inflammatory cells around blood vessels. Additionally, nitidine chloride inhibited the expression of various proinflammatory cytokines in the two animal models. In conclusion, our results are the first to demonstrate that nitidine chloride inhibits the proliferation of HaCaT cells, induces apoptosis partly via the JNK signaling pathway in vitro and ameliorates skin lesions and inflammation in vivo, making it an appropriate candidate for psoriasis treatment." @default.
• W2976456009 created "2019-10-03" @default.
• W2976456009 creator A5002803940 @default.
• W2976456009 creator A5008609733 @default.
• W2976456009 creator A5020147975 @default.
• W2976456009 creator A5029215411 @default.
• W2976456009 creator A5041554294 @default.
• W2976456009 creator A5042928177 @default.
• W2976456009 creator A5049798193 @default.
• W2976456009 creator A5050727001 @default.
• W2976456009 creator A5071023660 @default.
• W2976456009 creator A5071724777 @default.
• W2976456009 creator A5078047179 @default.
• W2976456009 date "2019-11-01" @default.
• W2976456009 modified "2023-10-17" @default.
• W2976456009 title "Nitidine chloride induces S phase cell cycle arrest and mitochondria-dependent apoptosis in HaCaT cells and ameliorates skin lesions in psoriasis-like mouse models" @default.
• W2976456009 cites W1915760257 @default.
• W2976456009 cites W1939997832 @default.
• W2976456009 cites W1974409934 @default.
• W2976456009 cites W1975640406 @default.
• W2976456009 cites W1979399988 @default.
• W2976456009 cites W1980643223 @default.
• W2976456009 cites W1981034346 @default.
• W2976456009 cites W1984846010 @default.
• W2976456009 cites W1987844651 @default.
• W2976456009 cites W1989600682 @default.
• W2976456009 cites W1991376100 @default.
• W2976456009 cites W1993776532 @default.
• W2976456009 cites W1995459263 @default.
• W2976456009 cites W1999840262 @default.
• W2976456009 cites W2000051219 @default.
• W2976456009 cites W2003427140 @default.
• W2976456009 cites W2016897508 @default.
• W2976456009 cites W2024503135 @default.
• W2976456009 cites W2033359295 @default.
• W2976456009 cites W2045095436 @default.
• W2976456009 cites W2055361229 @default.
• W2976456009 cites W2077625041 @default.
• W2976456009 cites W2079387868 @default.
• W2976456009 cites W2080090843 @default.
• W2976456009 cites W2080165152 @default.
• W2976456009 cites W2121126920 @default.
• W2976456009 cites W2138819828 @default.
• W2976456009 cites W2165226571 @default.
• W2976456009 cites W2211426328 @default.
• W2976456009 cites W2273122634 @default.
• W2976456009 cites W2332258267 @default.
• W2976456009 cites W2340071230 @default.
• W2976456009 cites W2568114277 @default.
• W2976456009 cites W2591368715 @default.
• W2976456009 cites W4230201118 @default.
• W2976456009 cites W4241172752 @default.
• W2976456009 doi "https://doi.org/10.1016/j.ejphar.2019.172680" @default.
• W2976456009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31563649" @default.
• W2976456009 hasPublicationYear "2019" @default.
• W2976456009 type Work @default.
• W2976456009 sameAs 2976456009 @default.
• W2976456009 citedByCount "16" @default.
• W2976456009 countsByYear W29764560092020 @default.
• W2976456009 countsByYear W29764560092021 @default.
• W2976456009 countsByYear W29764560092022 @default.
• W2976456009 countsByYear W29764560092023 @default.
• W2976456009 crossrefType "journal-article" @default.
• W2976456009 hasAuthorship W2976456009A5002803940 @default.
• W2976456009 hasAuthorship W2976456009A5008609733 @default.
• W2976456009 hasAuthorship W2976456009A5020147975 @default.
• W2976456009 hasAuthorship W2976456009A5029215411 @default.
• W2976456009 hasAuthorship W2976456009A5041554294 @default.
• W2976456009 hasAuthorship W2976456009A5042928177 @default.
• W2976456009 hasAuthorship W2976456009A5049798193 @default.
• W2976456009 hasAuthorship W2976456009A5050727001 @default.
• W2976456009 hasAuthorship W2976456009A5071023660 @default.
• W2976456009 hasAuthorship W2976456009A5071724777 @default.
• W2976456009 hasAuthorship W2976456009A5078047179 @default.
• W2976456009 hasConcept C118995209 @default.
• W2976456009 hasConcept C164027704 @default.
• W2976456009 hasConcept C185592680 @default.
• W2976456009 hasConcept C190283241 @default.
• W2976456009 hasConcept C199835354 @default.
• W2976456009 hasConcept C202751555 @default.
• W2976456009 hasConcept C203014093 @default.
• W2976456009 hasConcept C2776914184 @default.
• W2976456009 hasConcept C2780564577 @default.
• W2976456009 hasConcept C29537977 @default.
• W2976456009 hasConcept C502942594 @default.
• W2976456009 hasConcept C55493867 @default.
• W2976456009 hasConcept C86803240 @default.
• W2976456009 hasConcept C95444343 @default.
• W2976456009 hasConcept C98274493 @default.
• W2976456009 hasConceptScore W2976456009C118995209 @default.
• W2976456009 hasConceptScore W2976456009C164027704 @default.
• W2976456009 hasConceptScore W2976456009C185592680 @default.
• W2976456009 hasConceptScore W2976456009C190283241 @default.
• W2976456009 hasConceptScore W2976456009C199835354 @default.
• W2976456009 hasConceptScore W2976456009C202751555 @default.
• W2976456009 hasConceptScore W2976456009C203014093 @default.
• W2976456009 hasConceptScore W2976456009C2776914184 @default.
• W2976456009 hasConceptScore W2976456009C2780564577 @default.

• next